ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis
Colon adenocarcinoma (COAD) is one of the leading causes of cancer-associated deaths worldwide. Patients with microsatellite instability-high (MSI-H) tumors were shown to highly benefit from immune checkpoint inhibitors (ICIs) than patients with microsatellite stable (MSS) tumors. Furthermore, the i...
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Frontiers Media S.A.
2022-06-01
|
Schriftenreihe: | Frontiers in Immunology |
Schlagworte: | |
Online Zugang: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.829640/full |